Emodin azide methyl anthraquinone derivative induced G0/ G1 arrest in HER2/neu-overexpressing MDA-MB-453 breast cancer cells

J BUON. 2014 Jul-Sep;19(3):650-5.

Abstract

Purpose: Our previous data have shown that emodin azide methyl anthraquinone derivative (AMAD) triggered mitochondrial- dependent cell apoptosis involving caspase-8-mediated Bid cleavage, and induced proteasomal degradation of HER2/neu by blocking Her2/neu binding to Hsp90. In the present study, we futher investigated the effect of this compound on the cell cycle and related molecular mechanisms in HER2/neu-overexpressing MDA-MB-453 breast cancer cells.

Methods: The cell cycle distribution was tested by flow cytometry. The expression of cell cycle-related proteins was determined by Western blot analysis; DNA agarose gel electrophoresis was used to examine the apoptosis of MDAMB- 453 cells induced by emodin AMAD.

Results: After MDA-MB-453 cells were treated with different concentrations of emodin AMAD for 24 hrs, cells were arrested in G0/G1 phase, and the expression of G0/G1 related proteins c/Myc, Cyclin D1, CDK4 and p-Rb changed. DNA fragmentation appeared on the agarose gel in a concentration- dependent manner.

Conclusion: Emodin AMAD induced G0/G1 arrest in Her2/ neu-overexpressing MDA-MB-453 cancer cells. This G0/G1 arrest was associated with decreasing protein expression of c-Myc, Cyclin D1, CDK4, and p-Rb.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anthraquinones / pharmacology*
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Azides / pharmacology*
  • Cell Cycle Checkpoints / drug effects*
  • Cell Line, Tumor
  • Cyclin D1 / analysis
  • Cyclin-Dependent Kinase 4 / analysis
  • Emodin / analogs & derivatives*
  • Emodin / pharmacology*
  • Female
  • G1 Phase / drug effects
  • Humans
  • Receptor, ErbB-2 / analysis*
  • Resting Phase, Cell Cycle / drug effects

Substances

  • 6-azidomethyl-1-hydroxy-3,8-dimethoxy-9,10-anthraquinone
  • Anthraquinones
  • Antineoplastic Agents
  • Azides
  • CCND1 protein, human
  • Cyclin D1
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • CDK4 protein, human
  • Cyclin-Dependent Kinase 4
  • Emodin